Daniel Kramer

Daniel Kramer is a Research Scientist at Tally Health, a consumer biotechnology company focused on epigenetics and human longevity. Previously, he was an operations manager at Calibrate Health and a clinical researcher at Cornell University. He was also an early team member at the Harvard-incubated startups TetraScience and edX, and his writing and research have been featured in The New York Times and Nature Medicine. Danny graduated magna cum laude from Harvard College in Chemical Biology & Mathematics, where he was a teaching fellow in Chemistry and Mathematics and News Director at WHRB. He's currently on the board of directors of the Harvard Club of New York Foundation in New York City, where he's lived since graduating in 2015.